Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.093 | 0.6 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.12 | 0.6 |